LJI and Synbal, Inc. partner to develop better COVID-19 models

(La Jolla Institute for Immunology) The La Jolla Institute for Immunology (LJI) is partnering with Synbal, Inc., a preclinical biotechnology company based in San Diego, CA, to develop multi-gene, humanized mouse models for COVID-19 research. The research at LJI will be led by Professor Sujan Shresta, Ph.D., a member of the Institute's Center for Infectious Disease and Vaccine Research.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news